+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Caspofungin Market by Indication, Formulation, Product Type, End User, Distribution Channel - Global Forecast to 2030- Product Image
Caspofungin Market by Indication, Formulation, Product Type, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Caspofungin Market by Indication, Formulation, Product Type, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5968352
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Caspofungin Market is undergoing continued evolution, driven by shifts in antifungal therapy standards, supply chain realignment, and increasing clinical demand in both acute and specialized care. Senior decision-makers seeking clarity on industry forces, regional adoption patterns, and competitive positioning will find targeted insights in this detailed research analysis.

Market Snapshot: Caspofungin Market Size and Growth

The Caspofungin Market grew from USD 643.80 million in 2024 to USD 673.47 million in 2025 and is projected to reach USD 833.45 million by 2030, reflecting a CAGR of 4.39%. This growth is shaped by expanding clinical indications, rising prevalence of invasive fungal infections, and ongoing pipeline developments in both branded and generic products. Strategic realignment is being seen as stakeholders respond to new regulatory, pricing, and procurement dynamics across major geographies.

Scope & Segmentation

This comprehensive report offers a detailed breakdown of the Caspofungin Market, covering product forms, target conditions, distribution pathways, and end users across major global regions and sub-markets. The research evaluates each segment’s relevance to current market momentum and strategic opportunities.

  • Indication: Esophageal Candidiasis, Invasive Aspergillosis, Invasive Candidiasis
  • Formulation: Lyophilized Powder, Pre-mixed Solution
  • Product Type: Branded, Generic
  • End User: General Clinics, Specialty Clinics, Public Hospitals, Private Hospitals
  • Distribution Channel: Hospital Pharmacy, Chain Pharmacy, Independent Pharmacy
  • Regions: Americas (United States by state, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, and others), Asia-Pacific (China, India, Japan, Australia, and more)
  • Leading Companies: Merck & Co., Inc., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., Viatris Inc., Natco Pharma Limited, Biocon Limited, Cipla Limited, Dr. Reddy's Laboratories Limited, Apotex Inc., Fresenius Kabi AG

Caspofungin Market: Key Takeaways for Leaders

  • Growing need for targeted antifungal agents positions caspofungin as a preferred option in settings with rising immunotherapy and resistance concerns.
  • Shifts in clinical guidance and adoption of rapid diagnostics increase demand for fast-acting, versatile antifungal treatments that integrate with modern workflows.
  • The balance between branded caspofungin’s established clinical trust and the accelerated growth of generics is shaping purchasing patterns and cost-containment priorities.
  • Advances in formulation technology, especially the adoption of pre-mixed solutions, support operational efficiency and risk mitigation in hospital and specialized care environments.
  • Distribution channel optimization, including expansion into retail and chain pharmacies, enhances accessibility and ensures consistent supply to a broader patient base.
  • Proactive investment in decision-support technologies and stewardship services will help organizations realize better therapeutic outcomes and align with evolving care models.

Tariff Impact on Supply Chain Strategies

The introduction of new US tariffs in 2025 creates added complexity for manufacturers and procurement teams in the caspofungin supply chain. Adjustments in raw material sourcing, contract renegotiations, and cost controls are influencing procurement approaches. Collaborative efforts between manufacturers and healthcare providers support resilience and continuity of supply during this transitional period, helping stakeholders mitigate tariff-driven price fluctuations and budget impacts.

Methodology & Data Sources

The analysis integrates qualitative and quantitative research methods. Primary insights are obtained from interviews with clinical experts, pharmacists, and procurement leaders, supplemented by a thorough review of clinical literature, regulatory filings, and hospital system data. Cross-verification with reimbursement databases and global trade data ensures an accurate and well-rounded view of caspofungin market trends and segmentation.

Why This Report Matters

  • Enables informed strategic decisions on expansion, product development, and procurement by mapping emerging trends and risks.
  • Provides competitive benchmarking across regions and channels for optimal resource allocation and market entry.
  • Delivers actionable intelligence on tariff impacts, supply chain adaptation, and technology adoption for sustained performance.

Conclusion

Understanding caspofungin’s evolving role in antifungal therapy is essential to navigating market shifts shaped by clinical innovation, policy change, and competitive dynamics. This report enables stakeholders to identify priorities and optimize strategies for sustained growth and resilience.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Caspofungin Market, by Indication
8.1. Introduction
8.2. Esophageal Candidiasis
8.3. Invasive Aspergillosis
8.4. Invasive Candidiasis
9. Caspofungin Market, by Formulation
9.1. Introduction
9.2. Lyophilized Powder
9.3. Pre-mixed Solution
10. Caspofungin Market, by Product Type
10.1. Introduction
10.2. Branded
10.3. Generic
11. Caspofungin Market, by End User
11.1. Introduction
11.2. Clinics
11.2.1. General Clinics
11.2.2. Specialty Clinics
11.3. Hospitals
11.3.1. Private Hospitals
11.3.2. Public Hospitals
12. Caspofungin Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Retail Pharmacy
12.3.1. Chain Pharmacy
12.3.2. Independent Pharmacy
13. Americas Caspofungin Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Caspofungin Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Caspofungin Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Merck & Co., Inc.
16.3.2. Sandoz International GmbH
16.3.3. Teva Pharmaceutical Industries Ltd.
16.3.4. Viatris Inc.
16.3.5. Natco Pharma Limited
16.3.6. Biocon Limited
16.3.7. Cipla Limited
16.3.8. Dr. Reddy's Laboratories Limited
16.3.9. Apotex Inc.
16.3.10. Fresenius Kabi AG
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CASPOFUNGIN MARKET MULTI-CURRENCY
FIGURE 2. CASPOFUNGIN MARKET MULTI-LANGUAGE
FIGURE 3. CASPOFUNGIN MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CASPOFUNGIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CASPOFUNGIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CASPOFUNGIN MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CASPOFUNGIN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CASPOFUNGIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CASPOFUNGIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CASPOFUNGIN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CASPOFUNGIN MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CASPOFUNGIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CASPOFUNGIN MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CASPOFUNGIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CASPOFUNGIN MARKET SIZE, BY ESOPHAGEAL CANDIDIASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CASPOFUNGIN MARKET SIZE, BY INVASIVE ASPERGILLOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CASPOFUNGIN MARKET SIZE, BY INVASIVE CANDIDIASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CASPOFUNGIN MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CASPOFUNGIN MARKET SIZE, BY PRE-MIXED SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CASPOFUNGIN MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CASPOFUNGIN MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CASPOFUNGIN MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CASPOFUNGIN MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CASPOFUNGIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CASPOFUNGIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CASPOFUNGIN MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CASPOFUNGIN MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CASPOFUNGIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CASPOFUNGIN MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CASPOFUNGIN MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES CASPOFUNGIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 49. CANADA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 50. CANADA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 51. CANADA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. CANADA CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. CANADA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 54. CANADA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 55. CANADA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. CANADA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 57. MEXICO CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 58. MEXICO CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 59. MEXICO CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. MEXICO CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. MEXICO CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 62. MEXICO CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 63. MEXICO CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. MEXICO CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 98. GERMANY CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. GERMANY CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 100. GERMANY CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. GERMANY CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. GERMANY CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 103. GERMANY CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 104. GERMANY CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. GERMANY CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 106. FRANCE CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 107. FRANCE CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 108. FRANCE CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. FRANCE CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. FRANCE CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 111. FRANCE CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 112. FRANCE CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. FRANCE CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 122. ITALY CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. ITALY CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 124. ITALY CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. ITALY CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. ITALY CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 127. ITALY CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 128. ITALY CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. ITALY CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 130. SPAIN CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 131. SPAIN CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 132. SPAIN CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. SPAIN CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. SPAIN CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 135. SPAIN CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 136. SPAIN CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. SPAIN CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 146. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 147. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 148. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 151. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 154. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 155. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 156. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 162. DENMARK CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 163. DENMARK CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 164. DENMARK CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. DENMARK CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. DENMARK CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 167. DENMARK CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 168. DENMARK CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. DENMARK CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 178. QATAR CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 179. QATAR CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 180. QATAR CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. QATAR CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. QATAR CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 183. QATAR CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 184. QATAR CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. QATAR CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 186. FINLAND CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 187. FINLAND CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 188. FINLAND CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. FINLAND CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. FINLAND CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 191. FINLAND CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 192. FINLAND CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. FINLAND CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 194. SWEDEN CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 195. SWEDEN CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 196. SWEDEN CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. SWEDEN CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. SWEDEN CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 199. SWEDEN CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 210. EGYPT CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 211. EGYPT CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 212. EGYPT CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 213. EGYPT CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. EGYPT CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 215. EGYPT CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 216. EGYPT CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. EGYPT CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 218. TURKEY CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 219. TURKEY CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 220. TURKEY CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. TURKEY CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. TURKEY CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 223. TURKEY CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 224. TURKEY CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. TURKEY CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 226. ISRAEL CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 227. ISRAEL CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 228. ISRAEL CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. ISRAEL CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. ISRAEL CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 234. NORWAY CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 235. NORWAY CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 236. NORWAY CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. NORWAY CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. NORWAY CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 239. NORWAY CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 240. NORWAY CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. NORWAY CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 242. POLAND CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 243. POLAND CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 244. POLAND CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. POLAND CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. POLAND CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 247. POLAND CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 248. POLAND CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. POLAND CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 250. SWITZERLAND CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 251. SWITZERLAND CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 252. SWITZERLAND CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. SWITZERLAND CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 258. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 259. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 260. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 267. CHINA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 268. CHINA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 269. CHINA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 270. CHINA CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. CHINA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 272. CHINA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 273. CHINA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. CHINA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 275. INDIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 276. INDIA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 277. INDIA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. INDIA CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. INDIA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 280. INDIA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 281. INDIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. INDIA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 283. JAPAN CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 284. JAPAN CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 285. JAPAN CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 286. JAPAN CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. JAPAN CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 288. JAPAN CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 289. JAPAN CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 290. JAPAN CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 291. AUSTRALIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 292. AUSTRALIA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 293. AUSTRALIA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 294. AUSTRALIA CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. AUSTRALIA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 299. SOUTH KOREA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 300. SOUTH KOREA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 301. SOUTH KOREA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 302. SOUTH KOREA CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. SOUTH KOREA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 307. INDONESIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 308. INDONESIA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 309. INDONESIA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 310. INDONESIA CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. INDONESIA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 312. INDONESIA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 315. THAILAND CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 316. THAILAND CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 317. THAILAND CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 318. THAILAND CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. THAILAND CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 320. THAILAND CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 321. THAILAND CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 322. THAILAND CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 323. PHILIPPINES CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 324. PHILIPPINES CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 325. PHILIPPINES CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 326. PHILIPPINES CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 327. PHILIPPINES CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 328. PHILIPPINES CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 331. MALAYSIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 332. MALAYSIA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 333. MALAYSIA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 334. MALAYSIA CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 335. MALAYSIA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 336. MALAYSIA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 337. MALAYSIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 338. MALAYSIA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 339. SINGAPORE CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 340. SINGAPORE CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 341. SINGAPORE CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 342. SINGAPORE CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 343. SINGAPORE CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 344. SINGAPORE CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 345. SINGAPORE CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 346. SINGAPORE CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 347. VIETNAM CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 348. VIETNAM CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 349. VIETNAM CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 350. VIETNAM CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 351. VIETNAM CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 352. VIETNAM CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 353. VIETNAM CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 354. VIETNAM CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 355. TAIWAN CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 356. TAIWAN CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 357. TAIWAN CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 358. TAIWAN CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 359. TAIWAN CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 360. TAIWAN CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 361. TAIWAN CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 362. TAIWAN CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 363. CASPOFUNGIN MARKET SHARE, BY KEY PLAYER, 2024
TABLE 364. CASPOFUNGIN MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Caspofungin market report include:
  • Merck & Co., Inc.
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Natco Pharma Limited
  • Biocon Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories Limited
  • Apotex Inc.
  • Fresenius Kabi AG

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 673.47 Million
Forecasted Market Value ( USD ) by 2030 $ 833.45 Million
Compound Annual Growth Rate4.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Caspofungin - Global Strategic Business Report - Product Image

Caspofungin - Global Strategic Business Report

  • Report
  • 279 Pages
  • Global
From
Cryptococcosis Market by Drug Class, Indication, Route Of Administration, End User, Distribution Channel, Patient Type - Global Forecast to 2030 - Product Image

Cryptococcosis Market by Drug Class, Indication, Route Of Administration, End User, Distribution Channel, Patient Type - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Fungal Keratitis Treatment Market by Treatment Modality, Drug Class, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Fungal Keratitis Treatment Market by Treatment Modality, Drug Class, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Antifungal Drugs Market Report by Drug Class, Indication, and Region 2024-2032 - Product Image

Antifungal Drugs Market Report by Drug Class, Indication, and Region 2024-2032

  • Report
  • 147 Pages
  • Global
From
Candidemia - Pipeline Insight, 2025 - Product Image

Candidemia - Pipeline Insight, 2025

  • Clinical Trials
  • 40 Pages
  • Global
From

About the Caspofungin Market

Caspofungin is an antifungal drug used to treat a variety of fungal infections, including those caused by Candida species. It is a member of the echinocandin class of antifungal drugs, which are used to treat serious fungal infections in immunocompromised patients. Caspofungin is typically used in combination with other antifungal drugs, such as amphotericin B or fluconazole, to treat infections that are resistant to other antifungal agents. It is also used to treat infections caused by Aspergillus species, which are often difficult to treat. Caspofungin is an important drug in the treatment of infectious diseases, as it is effective against a wide range of fungal infections. It is also well tolerated, with few side effects. As such, it is an important part of the infectious diseases drugs market. Companies in the caspofungin market include Merck & Co., Pfizer, Astellas Pharma, and Bristol-Myers Squibb. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.